ESTRO 2022 - Abstract Book

S1184

Abstract book

ESTRO 2022

Conclusion PSMA-PET can represent an optimal imaging modality to identify failure-sites at early stages of biochemical relapse in prostate cancer patients initially treated with RP plus PB-RT(± ADT).

PO-1397 Quality of life in prostate cancer patients treated with a definitive radiotherapy

M. Li 1 , J. Ma 1 , P. Rogowski 1 , C. Trapp 1 , N. Schmidt-Hegemann 1 , C. Belka 1 , R. Bestenbostel 1

1 University Hospital, LMU Munich, Department of Radiation Oncology, Munich, Germany

Purpose or Objective To evaluate the quality of life in patients with localized prostate cancer treated with a definitive radiotherapy (RT) using EORTC QLQ-C30 and -PR25 questionnaires.